These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 3053082)
1. [Effects of intensified insulin therapy on fat metabolism in type 1 diabetes mellitus]. Dzien A; Drexel H; Hopferwieser T; Patsch JR; Braunsteiner H Dtsch Med Wochenschr; 1988 Oct; 113(43):1669-72. PubMed ID: 3053082 [TBL] [Abstract][Full Text] [Related]
2. Increased levels of HDL-cholesterol and apolipoprotein A-I after intensified insulin therapy for diabetes. Wilson DP; Fesmire JD; Endres RK; Blackett PR South Med J; 1985 Jun; 78(6):636-8. PubMed ID: 3923627 [TBL] [Abstract][Full Text] [Related]
3. Lipoprotein metabolism in patients with type 1 diabetes under intensive insulin treatment. Feitosa AC; Feitosa-Filho GS; Freitas FR; Wajchenberg BL; Maranhão RC Lipids Health Dis; 2013 Feb; 12():15. PubMed ID: 23398881 [TBL] [Abstract][Full Text] [Related]
4. [Correlation of the levels of glycosylated hemoglobin and total cholesterol, total triglycerides and HDL cholesterol in a sample of insulin-dependent diabetics]. Ezcurra Ferrer EJ; Licea Puig M; Reyes Durán A Rev Clin Esp; 1989 Mar; 184(4):182-4. PubMed ID: 2740544 [TBL] [Abstract][Full Text] [Related]
5. Lack of a persistent reduction in serum lipid and apoprotein levels in insulin-dependent diabetic patients receiving intensified insulin treatment. Goldberg RB; Reeves ML; Seigler DE; Ryan EA; Miller N; Hsia SL; Skyler JS Acta Diabetol Lat; 1985; 22(2):93-101. PubMed ID: 3907233 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus: effect of glycemic control. Pérez A; Wägner AM; Carreras G; Giménez G; Sánchez-Quesada JL; Rigla M; Gómez-Gerique JA; Pou JM; de Leiva A Arch Intern Med; 2000 Oct; 160(18):2756-62. PubMed ID: 11025785 [TBL] [Abstract][Full Text] [Related]
7. Metabolic control affects plasma lipid and apolipoprotein levels in women, but not in men, with IDDM. Benzi L; Marchetti P; Giampietro O; Miccoli R; Pecori N; Sanna G; Caricato F; Giovannitti MG; Ciccarone AM; Navalesi R Acta Diabetol Lat; 1988; 25(2):149-54. PubMed ID: 3223190 [TBL] [Abstract][Full Text] [Related]
8. Long-term treatment of type I diabetes in 28 patients using two different implantable programmable pumps. Jeandidier N; Pinget M; Keipes M; Louy S; Charton MN; Marescaux J; Reville P Transplant Proc; 1992 Jun; 24(3):940-1. PubMed ID: 1604674 [No Abstract] [Full Text] [Related]
9. Effect of alpha-glucosidase inhibition on glucose profiles in insulin dependent diabetes. Hillman RJ; Scott M; Gray RS Diabetes Res; 1989 Feb; 10(2):81-4. PubMed ID: 2663321 [TBL] [Abstract][Full Text] [Related]
10. Long-term effect of intensified insulin treatment on lipid parameters in diabetes mellitus type I. Dzien A; Lechleitner M; Hopferwieser T; Drexel H; Patsch JR; Braunsteiner H Klin Wochenschr; 1991 Aug; 69(11):483-5. PubMed ID: 1921231 [TBL] [Abstract][Full Text] [Related]
11. Associations of serum lipids with metabolic control and diet in young subjects with insulin-dependent diabetes mellitus in Finland. Virtanen SM; Räsänen L; Virtanen M; Sippola H; Rilva A; Kaprio EA; Mäenpää J; Akerblom HK Eur J Clin Nutr; 1993 Feb; 47(2):141-9. PubMed ID: 8436092 [TBL] [Abstract][Full Text] [Related]
12. Serum lipids and glucose control: the SEARCH for Diabetes in Youth study. Petitti DB; Imperatore G; Palla SL; Daniels SR; Dolan LM; Kershnar AK; Marcovina S; Pettitt DJ; Pihoker C; Arch Pediatr Adolesc Med; 2007 Feb; 161(2):159-65. PubMed ID: 17283301 [TBL] [Abstract][Full Text] [Related]
13. Long-term comparison of human insulin analogue B10Asp and soluble human insulin in IDDM patients on a basal/bolus insulin regimen. Nielsen FS; Jørgensen LN; Ipsen M; Voldsgaard AI; Parving HH Diabetologia; 1995 May; 38(5):592-8. PubMed ID: 7489843 [TBL] [Abstract][Full Text] [Related]
14. Response of apolipoprotein AIV and lipoproteins to glycaemic control in young people with insulin-dependent diabetes mellitus. Attia N; Touzani A; Lahrichi M; Balafrej A; Kabbaj O; Girard-Globa A Diabet Med; 1997 Mar; 14(3):242-7. PubMed ID: 9088774 [TBL] [Abstract][Full Text] [Related]
15. Relationship of regional adiposity to insulin resistance and serum triglyceride levels in nonobese Japanese type 2 diabetic patients. Taniguchi A; Nakai Y; Sakai M; Yoshii S; Hamanaka D; Hatae Y; Kawata M; Yamanouchi K; Okumura T; Doi K; Tokuyama K; Nagasaka S; Fukushima M Metabolism; 2002 May; 51(5):544-8. PubMed ID: 11979383 [TBL] [Abstract][Full Text] [Related]
16. Ciprofibrate effects on carbohydrate and lipid metabolism in type 2 diabetes mellitus subjects. Hernández-Mijares A; Lluch I; Vizcarra E; Martínez-Triguero ML; Ascaso JF; Carmena R Nutr Metab Cardiovasc Dis; 2000 Feb; 10(1):1-6. PubMed ID: 10812581 [TBL] [Abstract][Full Text] [Related]
17. [Cholesterol, HDL-cholesterol, triglycerides and beta-lipoprotein in diabetic pregnancy]. Briese V; Müller H; Stiete H Zentralbl Gynakol; 1995; 117(1):17-22. PubMed ID: 7879456 [TBL] [Abstract][Full Text] [Related]
18. [Improved metabolic state in insulin-tested diabetes. Self-testing of blood or urine glucose on 2 days per week]. Koschinsky T; Toeller M; Berger H; Dannehl K; Dopstadt K; Yousefian M; Gries FA Dtsch Med Wochenschr; 1984 Feb; 109(5):174-9. PubMed ID: 6365501 [TBL] [Abstract][Full Text] [Related]
19. Effect of glycemic optimization on electronegative low-density lipoprotein in diabetes: relation to nonenzymatic glycosylation and oxidative modification. Sánchez-Quesada JL; Pérez A; Caixàs A; Rigla M; Payés A; Benítez S; Ordóñez-Llanos J J Clin Endocrinol Metab; 2001 Jul; 86(7):3243-9. PubMed ID: 11443196 [TBL] [Abstract][Full Text] [Related]
20. Correlations between glycosylated haemoglobin and other metabolic parameters in insulin-dependent diabetics. Odetti P; Ansaldi E; Diara C; Cheli V; Andraghetti G; Buzzo P; Prando R Diabete Metab; 1983 Mar; 9(1):26-31. PubMed ID: 6343150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]